news Monoclonal antibodies prevent COVID-19 inflammation in macaques 2 November 2021 | By Anna Begley (Drug Target Review) Neutralising monoclonal antibodies protected aged macaque monkeys from SARS-CoV-2 and reduced inflammation, including in cerebrospinal fluid, a new study has shown.
news Pathway and enzyme responsible for CKD thrombosis identified 2 November 2021 | By Anna Begley (Drug Target Review) Scientists have discovered a novel pathway and enzyme that causes thrombosis in chronic kidney disease (CKD) patients, indicating a new drug target.
podcast Episode 3 – Cell & gene therapy with Dr Sam Wadsworth, Ultragenyx Pharmaceutical & Dr Eric Ostertag, Poseida Therapeutics 1 November 2021 | By Drug Target Review Tune in to this podcast to learn about AAV vectors for gene therapy delivery and engineering CAR T cells against solid tumours.
news GLP-1 and GIP receptor agonists reduce mouse obesity in pre-clinical study 1 November 2021 | By Anna Begley (Drug Target Review) Treatment with Viking Therapeutics' dual agonists resulted in mean reductions in body weight of up to 27 percent compared to semaglutide-treated animals.
news Scientists eliminate key Alzheimer’s feature in animal model 1 November 2021 | By Anna Begley (Drug Target Review) Turning off NHE6 in mice in pre-clinical studies prevented amyloid beta aggregation, a key feature of Alzheimer's disease, pointing to new therapies.
news $9 million grant awarded to uncover whether Parkinson’s starts in the nose 29 October 2021 | By Anna Begley (Drug Target Review) A new grant will allow an international team to determine if scent-processing nerves in the nose play a role in the development of Parkinson's and could aid in the development of novel therapeutics.
news Machine learning models predict antibiotic resistance spread 29 October 2021 | By Anna Begley (Drug Target Review) Scientists have used several machine learning models to predict bacterial gene exchange, which could reveal novel antibiotic targets.
news Albert Einstein researcher receives NIC award to study two blood cancers 28 October 2021 | By Anna Begley (Drug Target Review) Professor Ulrich G Steidl received the National Institute of Cancer's Outstanding Investigator Award to study myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML).
news Scientists target ALS and dementia RNA using novel molecule 28 October 2021 | By Anna Begley (Drug Target Review) The small molecule successfully targeted the C9orf72 gene that causes amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
news Raman spectroscopy used to determine immunotherapy effectiveness 28 October 2021 | By Anna Begley (Drug Target Review) Researchers used Raman spectroscopy to monitor immunotherapy response in mice, potentially improving cancer treatments in the future.
news Groundbreaking data tool may uncover novel class of GPCRs 27 October 2021 | By Anna Begley (Drug Target Review) A new computer-aided tool maps allosteric sites in G protein-coupled receptors to search for allosteric drugs to treat a range of diseases.
news Experimental mouse model reveals potential progeria treatment strategy 27 October 2021 | By Anna Begley (Drug Target Review) Scientists have found that Hutchinson-Gilford Progeria Syndrome (HGPS) can be prevented with treatments targeting the cardiovascular system using a novel mouse model.
news Specific mechanism found to control transition from acute to chronic pain 27 October 2021 | By Anna Begley (Drug Target Review) A new study is the first to identify N-acylethanolamine acid amidase as a new drug target to treat different forms of chronic pain.
webinar Capturing biological complexity to empower biomarker discovery 27 October 2021 | By Takara Bio Sign up for this free webinar and discover how refined cell atlases can provide comprehensive roadmaps for health and disease.
news Molecular targets for breast cancer relapse identified in new study 26 October 2021 | By Anna Begley (Drug Target Review) German, Norwegian and British scientists have identified molecular targets for therapies that could prevent breast cancer recurrence.